|
|
||||||||
The FASEB Journal, Vol 2, 2339-2347, Copyright © 1988 by The Federation of American Societies for Experimental Biology
REVIEWS |
MP O'Donnell, BL Kasiske and WF Keane
Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis 55415.
Elevated glomerular filtration rate (GFR) is a frequent finding in patients with early insulin-dependent diabetes mellitus (IDDM). The mechanisms responsible for this glomerular hyperfiltration in IDDM are unclear. Rats made diabetic with alloxan or streptozotocin, and treated daily with supplemental insulin, have moderate hyperglycemia and elevated GFR, and thus have been used to study mechanisms of glomerular hyperfiltration in diabetes. Renal micropuncture techniques have shown that single-nephron GFR (SNGFR) is elevated in moderately hyperglycemic diabetic rats. In some cases, this is because of elevated glomerular capillary pressure (Pgc), but in other cases, Pgc is normal despite elevated SNGFR. Several potential mediators of increased SNGFR have been examined, including hyperglycemia, increased glomerular prostaglandin production, and decreased sensitivity of the tubuloglomerular feedback mechanism. Renal failure is a common complication of human IDDM. Diabetic rats with long-term moderate hyperglycemia have been used to study the mechanism by which glomerular injury develops in diabetes mellitus. It has been postulated that glomerular hyperfiltration or some determinant of elevated GFR in early diabetes may ultimately cause glomerular damage, leading to a progressive loss of renal function (diabetic nephropathy). Diabetic rats with long-term moderate hyperglycemia, however, do not develop characteristic glomerular lesions of human diabetic nephropathy and, in fact, develop only minimal glomerular injury even after 1 year of diabetes. Thus, although the diabetic rat with moderate hyperglycemia may be useful to study the mechanisms of glomerular hyperfiltration in early diabetes, it may not be an appropriate model of renal failure in IDDM.
This article has been cited by other articles:
![]() |
E. M. V. de Cavanagh, L. Ferder, J. E. Toblli, B. Piotrkowski, I. Stella, C. G. Fraga, and F. Inserra Renal mitochondrial impairment is attenuated by AT1 blockade in experimental Type I diabetes Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H456 - H465. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Lim, N. G. Morgenthaler, T. Subramaniam, Y. S. Wu, S. K. Goh, and C. F. Sum The Relationship Between Adrenomedullin, Metabolic Factors, and Vascular Function in Individuals With Type 2 Diabetes Diabetes Care, June 1, 2007; 30(6): 1513 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Bidani, M. Picken, R. Hacioglu, G. Williamson, and K. A. Griffin Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance Am J Physiol Renal Physiol, February 1, 2007; 292(2): F647 - F654. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hartner, N. Cordasic, B. Klanke, M. Wittmann, R. Veelken, and K. F. Hilgers Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes Am J Physiol Renal Physiol, February 1, 2007; 292(2): F820 - F827. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Lauer, V. C. Hascall, and A. Wang Heparan Sulfate Analysis from Diabetic Rat Glomeruli J. Biol. Chem., January 12, 2007; 282(2): 843 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Najafian, J. T. Crosson, Y. Kim, and M. Mauer Glomerulotubular Junction Abnormalities Are Associated with Proteinuria in Type 1 Diabetes J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S53 - S60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Meier and G. L King Protein kinase C activation and its pharmacological inhibition in vascular disease Vascular Medicine, August 1, 2000; 5(3): 173 - 185. [Abstract] [PDF] |
||||
![]() |
C. Tschope, A. Reinecke, U. Seidl, M. Yu, V. Gavriluk, U. Riester, P. Gohlke, K. Graf, M. Bader, U. Hilgenfeldt, et al. Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2333 - H2340. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Velasquez, J. S. Striffler, A. A. Abraham, O. E. Michaelis IV, E. Scalbert, and N. Thibault Perindopril Ameliorates Glomerular and Renal Tubulointerstitial Injury in the SHR/N-Corpulent Rat Hypertension, November 1, 1997; 30(5): 1232 - 1237. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |